Abstract:Helicobacter pylori, the world's most common chronic infection-causing pathogen, is responsible for causing gastric ulcers, the fourth-leading cause of cancer-related death globally in 2020. In recent years, the effectiveness of the current treatment regimen (two antibiotics and one proton pump inhibitor) has often been plagued with problems such as resistance and the undesired elimination of commensal bacteria. Herein, we report the synthesis of block and random copolycarbonates, functionalized with cationic guanidinium and anionic acetate functional groups, aimed at selectively killing H. pylori in the acidic environment of the stomach, while remaining nontoxic to the commensal bacteria in the gut. The compositions of the polymers were fine-tuned so that the polymers were readily dispersed in water without any difficulty at both pH 3.0 and 7.4. The self-assembly behavior of the polymers at different pH values by dynamic light scattering showed that the random and block copolymers formed stable micelles in a simulated gastric environment (pH 3.0) while aggregated at pH 7.4. Both polymers demonstrated stronger antibacterial activity against H. pylori than the guanidinium-functionalized homopolymer without any acetate functional group at pH 3.0. The block copolymer was significantly more bactericidal at pH 3.0 across the concentrations tested, as compared to the random copolymer, while it did not show significant toxicity toward rat red blood cells (rRBCs) and HK-2 cells or bactericidal effect toward E. coli (a common gut bacterium) and nor caused aggregation of rRBCs at its effective concentration and at physiological pH of 7.4. Additionally, both the block and random copolymers were much more stable against hydrolysis at pH 3.0 than at pH 7.4. This study provides insight into the influence of both polymer architecture and dynamic assembly on the bioactivities of antimicrobial polymers, where the disassembly of coacervates into narrowly dispersed micelles at pH 3 make them potent antimicrobials aided by the protonated carboxylic acid block.

Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.

Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori

Construction and Optimization of Ph-Sensitive Nanoparticle Delivery System Containing PLGA and UCCs-2 for Targeted Treatment of Helicobacter Pylori.

Development of Ph-Responsive Chitosan/Heparin Nanoparticles for Stomach-Specific Anti-Helicobacter Pylori Therapy

Evaluation of Chitosan Nanomaterials in the Treatment of Helicobacter Pylori Mediated Gastric Diseases

Effective Treatment of Helicobacter pylori Infection Using Supramolecular Antimicrobial Peptide Hydrogels

Anti-Helicobacter Pylori Effectiveness and Targeted Delivery Performance of Amoxicillin-Uccs-2/tpp Nanoparticles Based on Ureido-Modified Chitosan Derivative

Antimicrobial Peptide Hydrogel with pH-Responsive and Controllable Drug Release Properties for the Efficient Treatment of Helicobacter pylori Infection

Bacteria-targeting Chitosan/carbon Dots Nanocomposite with Membrane Disruptive Properties Improve Eradication Rate of Helicobacter Pylori

Preparation and Evaluation of Amoxicillin Loaded Dual Molecularly Imprinted Nanoparticles for Anti-Helicobacter Pylori Therapy.

Biodegradable Acid‐Responsive Nanocarrier for Enhanced Antibiotic Therapy Against Drug‐Resistant Helicobacter Pylori via Urease Inhibition

Design of Enzyme Decorated Mucopermeating Nanocarriers for Eradication of H. Pylori Infection

Amoxicillin-loaded Nanotechnological Carriers for the Effective Treatment of Helicobacter pylori Infection

Advances in micro/nanodrug delivery systems for the treatment of Helicobacter pylori infection: From diagnosis to eradication

Engineering Bioinspired Bacteria-Adhesive Clay Nanoparticles with A Membrane-Disruptive Property for the Treatment of Helicobacter Pylori Infection

Preparation and Evaluation of Lipid Polymer Nanoparticles for Eradicating H-Pylori Biofilm and Impairing Antibacterial Resistance in Vitro

Synergistic effects of nanoparticle heating and amoxicillin on H. pylori inhibition

Development and Evaluation of Novel Amoxicillin and Phytic Acid-Loaded Gastro-Retentive Mucoadhesive Pectin Microparticles for the Management of Helicobacter pylori Infections

Eradication of Helicobacter pylori : the power of nanosized formulations.

pH-Responsive Polymeric Micelle Dynamic Complexes for Selective Killing of Helicobacter pylori

Amoxicillin-docosahexaenoic acid encapsulated chitosan-alginate nanoparticles as a delivery system with enhanced biocidal activities against Helicobacter pylori and improved ulcer healing